Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXYDOPA Trial
NCT02601586Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2016
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone, levodopa in central neuropathic pain (CNP), sponsored by Centre hospitalier universitaire de Toulouse. Started Sep 2016; status: completed.
02
Drugs
oxycodonelevodopa
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on NCT02601586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601586.